AMESITE OPER. DL-,0001

Amesite completed multiple stock and warrant issuances that generated gross proceeds of approximately $2.6 million for the company, including a registered direct placement and private placements at $1.435 per share. Investors received warrants (Series A-1 and A-2) to acquire additional shares; if fully exercised for cash, roughly another $5.2 million could be raised. Buyers included insiders, including CEO Dr. Ann Marie Sastry and board member George Parmer. Amesite intends to use the net proceeds for general corporate purposes and working capital and expects to meet NASDAQ's minimum stockholders' equity requirement following the issuances. » More on de.investing.com

Amesite has entered agreements for a registered direct offering and an accompanying private placement, under which 696,866 common shares are to be sold in each offering at $1.435 per share. In addition, Series A‑1 (five‑year) and A‑2 (18‑month) warrants exercisable for up to 696,866 shares each will be issued; their exercise requires shareholder approval. Expected gross proceeds are about $2 million; if the warrants are fully exercised for cash, roughly an additional $4 million would be possible. Amesite intends to use the net proceeds for general corporate purposes and working capital. » More on de.investing.com